Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.91% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.04% |
| 4 | Consumer Discretionary | 4.86% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFVL
1301
DELISTED
iPath US Treasury 5-year Bull ETN
DFVL
| $5.87M | ﹤0.01% |
67,400
| – | – |
|
|
DTUL
1302
DELISTED
iPath US Treasury 2-year Bull ETN
DTUL
| $5.87M | ﹤0.01% |
78,000
| – | – |
|
1303
PUT
Workday
WDAY
$44.8B
| $5.85M | ﹤0.01% |
27,200
+14,500
| +114% | +$2.87M |
|
1304
Colliers International
CIGI
$5.3B
| $5.84M | ﹤0.01% |
+87,622
| New | +$5.33M |
|
1305
Globus Medical
GMED
$11.4B
| $5.83M | ﹤0.01% |
117,740
+82,079
| +230% | +$4.23M |
|
1306
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
| $5.82M | ﹤0.01% |
52,700
-3,800
| -7% | -$419K |
|
|
BAL
1307
DELISTED
iPath Series B Bloomberg Cotton Subindex Total ReturnSM ETN
BAL
| $5.79M | ﹤0.01% |
149,000
| – | – |
|
|
MDC
1308
DELISTED
M.D.C. Holdings, Inc.
MDC
| $5.79M | ﹤0.01% |
132,750
+37,608
| +40% | +$1.5M |
|
|
TCO
1309
DELISTED
Taubman Centers Inc.
TCO
| $5.77M | ﹤0.01% |
173,459
+39,676
| +30% | +$1.48M |
|
|
NOAH
1310
Noah Holdings
NOAH
$591M
| $5.77M | ﹤0.01% |
221,287
+184,234
| +497% | +$5.43M |
|
1311
Credicorp
BAP
$30B
| $5.76M | ﹤0.01% |
46,475
+234
| +0.5% | +$30.1K |
|
1312
Yeti Holdings
YETI
$3.85B
| $5.71M | ﹤0.01% |
125,924
+42,200
| +50% | +$2M |
|
1313
iShares TIPS Bond ETF
TIP
$14.7B
| $5.7M | ﹤0.01% |
45,095
-8,247
| -15% | -$1.04M |
|
1314
Twist Bioscience
TWST
$7.72B
| $5.69M | ﹤0.01% |
74,903
+44,320
| +145% | +$2.76M |
|
1315
SLM Corp
SLM
$5.11B
| $5.67M | ﹤0.01% |
700,455
+667,599
| +2,032% | +$4.88M |
|
1316
Exponent
EXPO
$3.25B
| $5.65M | ﹤0.01% |
78,404
+16,073
| +26% | +$1.28M |
|
1317
HSBC
HSBC
$355B
| $5.64M | ﹤0.01% |
288,143
-84,334
| -23% | -$1.85M |
|
|
MPT
1318
Medical Properties Trust
MPT
$2.4B
| $5.63M | ﹤0.01% |
319,599
-219,578
| -41% | -$4.09M |
|
|
DOC
1319
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $5.62M | ﹤0.01% |
313,801
+122,530
| +64% | +$2.18M |
|
|
SGI
1320
CALL
Somnigroup International
SGI
$13.7B
| $5.61M | ﹤0.01% |
251,600
| – | – |
|
1321
BHP
BHP
$229B
| $5.61M | ﹤0.01% |
121,612
+6,211
| +5% | +$299K |
|
1322
Perrigo
PRGO
$1.78B
| $5.58M | ﹤0.01% |
121,671
+20,113
| +20% | +$1.05M |
|
1323
Manhattan Associates
MANH
$11.4B
| $5.58M | ﹤0.01% |
58,476
+38,737
| +196% | +$3.67M |
|
|
ARNA
1324
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.56M | ﹤0.01% |
+74,300
| New | +$4.95M |
|
1325
iShares Expanded Tech-Software Sector ETF
IGV
$14.9B
| $5.54M | ﹤0.01% |
89,020
+10,750
| +14% | +$646K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.